Interestingly, we observed that MSI2 upregulation in SOX11+ MCL cells was associated with specific epigenetic changes compared to SOX11– MCLs or normal B cells, suggesting that active MSI2 intronic enhancers may be responsible, in part, for MSI2 upregulation in MCL. The gene discussed is MSI2; the disease is mantle cell lymphoma.